Blue light even at longer wavelengths shows antifibrotic activity and may represent a suitable and safe approach in the treatment of fibrotic skin diseases including hypertrophic scarring and scleroderma. Link to abstract
PHLECS winner of the EIT Health’s Bridgehead Global program 2020
Dutch MedTech start-up PHLECS has just been selected by EIT Health to participate in its Bridgehead Global program. After receiving the CE marking for its Full Body Blue Light device last March, PHLECS is now moving forward to its next business milestone ...
PHLECS, a Dutch start-up that launches a new drug-free therapy for psoriasis
The Dutch MedTech start-up has just obtained the medical CE marking for the Full Body Blue Light Device and will start its commercialization in Europe from April 2020 onwards. Press release
Phlecs, the first start-up to address patient unmet needs with UV free phototherapy treatments
Phlecs was founded last April 2019 in Eindhoven, the Netherlands and has completed last May the first financing round with private investors. We are now focusing on the ISO13485 certification of our Quality Management System and the CE marking of the ful ...